Gardner Lewis Asset Management’s Edwards Lifesciences EW Stock Holding History

Gardner Lewis Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-29,965	Closed	-$2.51M	–	83
2021 Q1	$2.51M	Hold	29,965	–	–	0.45%	61
2020 Q4	$2.73M	Buy	29,965 +4,495	+18%	+$373K	0.64%	47
2020 Q3	$2.03M	Buy	25,470 +5,850	+30%	+$456K	0.37%	50
2020 Q2	$1.36M	Buy	19,620 +1,488	+8%	+$106K	0.25%	60
2020 Q1	$1.14M	Buy	+18,132	New	+$1.31M	0.19%	68
2018 Q1	–	Sell	-46,035	Closed	-$1.73M	–	93
2017 Q4	$1.73M	Buy	+46,035	New	+$1.69M	0.15%	73
2017 Q1	–	Sell	-31,779	Closed	-$993K	–	98
2016 Q4	$993K	Buy	+31,779	New	+$1.03M	0.08%	94

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Gardner Lewis Asset Management's EW Position: Q2 2021 in Review

Gardner Lewis Asset Management sold out of Edwards Lifesciences (EW) in Q2 2021, closing a stake of 29,965 shares — an estimated $2.51M sold.

Gardner Lewis Asset Management first reported a position in EW in Q4 2016 and held it in 7 quarters. The position peaked at $2.73M in Q4 2020. 1,188 funds tracked by Wall St. Rank hold EW as of Q2 2021.

Gardner Lewis Asset Management reported no remaining Edwards Lifesciences position as of Q2 2021 after selling out during the quarter.
Gardner Lewis Asset Management sold 29,965 Edwards Lifesciences shares in Q2 2021, an estimated $2.51M.
Gardner Lewis Asset Management first reported a position in Edwards Lifesciences in Q4 2016 and held it in 7 quarters.
Gardner Lewis Asset Management's Edwards Lifesciences position peaked at $2.73M in Q4 2020.
1,188 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.

Based on Gardner Lewis Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.